LGALS1 and pancreatic neoplasm: Although we conducted preliminary studies of the uptake dynamics of anti-Gal1-Fe3O4 nanoparticles in the pancreatic tumors of nude mice, further pharmacokinetic/pharmacodynamic studies are required including dose escalation studies.